Galifold 123MG
Ended Awarded
- Contract number
- 36C24725N0280
- Awardee
-
Amicus Therapeutics US, LLC UEI KLJFGENKMD89 Part of Amicus Therapeutics, Inc.
- Awarding agency
-
Veterans Integrated Service Network 7
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $197,021
Award facts
- Contract value 100% obligated
- $197,020.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Philadelphia, PA 19104, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Amicus Therapeutics US, LLC, a subsidiary of Amicus Therapeutics, Inc. The contract is valued at $197,020.89 and has a completion date of May 31, 2025. The contract is for the delivery of the pharmaceutical product Galafold 123mg, an enzyme replacement therapy used to treat Fabry disease.
Amicus Therapeutics US, LLC holds a Federal Supply Schedule (FSS) contract (36F79724D0185) with the VA, which is a multiple-award, firm-fixed-price contract valued at $13,024,630 and valid through August 31, 2029. This contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) schedule and allows various VA Veterans Integrated Service Networks (VISNs) to place task orders for pharmaceutical products. The contract supports the VA's mission to provide specialized healthcare services and medications to veterans, ensuring continuous access to critical treatments for rare diseases. There is no set-aside designation for this contract.
Quick answers
Who was awarded contract 36C24725N0280?
36C24725N0280 was awarded to Amicus Therapeutics US, LLC by Veterans Integrated Service Network 7 (Veterans Health Administration) on January 21, 2025.
How much is contract 36C24725N0280 worth?
The government has obligated $197,021 on 36C24725N0280.
Is contract 36C24725N0280 an order under another contract?
Yes. 36C24725N0280 is a delivery order under 36F79724D0185, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24725N0280 competed?
The extent of competition for 36C24725N0280 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award